This article explores the pivotal role of chemogenomics libraries in deconvoluting the mechanism of action (MoA) for hits identified in phenotypic screens.
This article explores the integral role of chemogenomics in modern phenotypic drug discovery (PDD), a biology-first approach responsible for a disproportionate number of first-in-class medicines.
This article provides a comprehensive overview of chemogenomic compound libraries, which are curated collections of small molecules designed to systematically probe families of biological targets.
This article provides a comprehensive overview of chemogenomics, an innovative strategy that integrates combinatorial chemistry, genomics, and proteomics to systematically identify and validate novel therapeutic targets and bioactive compounds.
This article provides a comprehensive guide to the basic principles of chemogenomic library design for researchers, scientists, and drug development professionals.
This article provides a comprehensive comparison of genetic and pharmacological strategies for targeting intrinsic resistance mechanisms in disease treatment.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals on the validation of Epidemiological Cut-off (ECOFF) values and intrinsic resistance breakpoints.
This article provides a comprehensive comparative analysis of the intrinsic resistance mechanisms employed by ESKAPE pathogens—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species.
Multidrug-resistant Gram-negative bacteria pose an urgent global health threat, with efflux pumps like AcrB playing a major role in antibiotic failure.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for distinguishing between intrinsic and phenotypic antimicrobial resistance (AMR).